Loading stock data...
Last Updated: 10 Mar 2026, 03:30:00 PM (IST)

Entero Healthcare Solutions Limited

NSE: ENTERO

NSE
1,033.50 3.90 (0.38%)

Prev Close

1029.6

Open Price

1040

Volume

90,891

Today Low / High

1022 / 1050.9

52 WK Low / High

944 / 1510.8

Range

982 - 1,085

Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 1033.5, with a change of 3.9 (0.37879%). The expected target range on the NSE is between 982 - 1,085. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.

27 Feb 1,056.00 -2.27%
26 Feb 1,060.90 0.05%
25 Feb 1,038.90 2.12%
24 Feb 1,060.00 -2.99%
23 Feb 1,079.20 -1.59%
20 Feb 1,091.10 -1.09%
19 Feb 1,123.20 -2.86%
18 Feb 1,115.00 -0.75%
17 Feb 1,100.00 0.53%
16 Feb 1,157.80 -5.20%
13 Feb 1,159.00 -0.90%
12 Feb 1,158.30 -0.15%
11 Feb 1,145.00 0.32%
10 Feb 1,163.00 -0.99%

Entero Healthcare Solutions Limited Graph

Entero Healthcare Solutions Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Entero Healthcare Solutions Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,033.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,033.50 1,043.84 939.45 - 1,148.22
1,054.17 843.34 - 1,265.00
1,064.51 745.15 - 1,383.86
Bearish Scenario 1,033.50 1,023.17 920.85 - 1,125.48
1,012.83 810.26 - 1,215.40
1,002.50 701.75 - 1,303.24

Overview of Entero Healthcare Solutions Limited

ISIN

INE010601016

Industry

Medical - Distribution

Vol.Avg

146,057

Market Cap

44,903,286,984

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-02-16

DCF Diff

607.94

DCF

424

Financial Ratios Every Investor Needs

Stock Rating Details for ENTERO

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 5,095.78 Cr 4,839.21 Cr 256.57 Cr 0.0504 0.00 Cr 201.46 Cr 140.86 Cr 94.82 Cr 21.81 211.05 Cr 0.0186
2024-03-31 3,922.31 Cr 3,574.36 Cr 347.95 Cr 0.0887 0.00 Cr 151.82 Cr 86.83 Cr 39.11 Cr 10.81 126.11 Cr 0.0100
2023-03-31 3,300.21 Cr 3,031.87 Cr 110.46 Cr 0.0335 0.00 Cr 10.81 Cr 39.77 Cr -11.56 Cr -2.66 69.48 Cr -0.0035
2022-03-31 2,515.27 Cr 2,312.44 Cr 202.83 Cr 0.0806 0.00 Cr 13.74 Cr 4.68 Cr -29.92 Cr -6.88 26.04 Cr -0.0119
2021-03-31 1,773.10 Cr 1,638.14 Cr 134.96 Cr 0.0761 0.00 Cr 9.14 Cr 5.27 Cr -15.54 Cr -3.57 25.46 Cr -0.0088

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 260.42 Cr 2,702.52 Cr 932.16 Cr 1,724.1450 Cr 404.63 Cr 144.21 Cr 659.78 Cr 132.06 Cr 0.00 Cr 0.00 Cr 26.23 Cr 845.0170 Cr
2024-03-31 147.65 Cr 2,344.98 Cr 703.59 Cr 1,638.0560 Cr 337.97 Cr 190.33 Cr 421.16 Cr 93.09 Cr 0.00 Cr 0.00 Cr 5.44 Cr 601.9440 Cr
2023-03-31 25.36 Cr 1,404.10 Cr 776.34 Cr 622.9480 Cr 437.76 Cr 441.75 Cr 341.63 Cr 97.40 Cr 67.81 Cr 0.00 Cr -80.08 Cr 689.2340 Cr
2022-03-31 46.51 Cr 1,125.98 Cr 562.77 Cr 561.0410 Cr 354.63 Cr 308.12 Cr 310.16 Cr 108.12 Cr 50.25 Cr 0.00 Cr 0.00 Cr 461.7800 Cr
2021-03-31 32.31 Cr 833.79 Cr 346.73 Cr 485.3660 Cr 202.95 Cr 170.63 Cr 243.93 Cr 96.73 Cr 42.67 Cr 0.00 Cr 0.00 Cr 289.1270 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -80.3240 Cr 181.6980 Cr -32.0990 Cr -91.6380 Cr 112.7750 Cr 260.4210 Cr -11.3140 Cr 94.8200 Cr 21.7000 Cr 0.0000 Cr -146.5620 Cr
2024-03-31 -36.6120 Cr -705.1220 Cr 862.9400 Cr -42.0280 Cr 122.2840 Cr 147.6460 Cr -5.4160 Cr 35.5550 Cr -98.7620 Cr 0.0000 Cr -58.1830 Cr
2023-03-31 -45.3150 Cr -48.5950 Cr 72.7640 Cr -50.8340 Cr -21.1460 Cr 25.3620 Cr -5.5190 Cr -3.2620 Cr 88.4870 Cr 0.0000 Cr -19.3940 Cr
2022-03-31 -35.2660 Cr -161.7320 Cr 211.1920 Cr -45.1320 Cr 14.1940 Cr 46.5080 Cr -9.8660 Cr -19.8110 Cr 143.3250 Cr 0.0000 Cr -30.0970 Cr
2021-03-31 -68.6840 Cr -30.8690 Cr 88.7130 Cr -78.2130 Cr -10.8400 Cr 32.3140 Cr -9.5290 Cr -10.8380 Cr 35.2340 Cr 0.0000 Cr -48.9510 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 1,706.52 Cr 1,533.93 Cr 172.59 Cr 0.1011 57.98 Cr 27.63 Cr 6.35 64.21 Cr 0.0162
2025-09-30 1,570.95 Cr 1,410.15 Cr 160.80 Cr 0.1024 52.23 Cr 31.60 Cr 7.26 66.86 Cr 0.0201
2025-06-30 1,403.82 Cr 1,264.25 Cr 139.57 Cr 0.0994 41.20 Cr 27.80 Cr 6.39 55.90 Cr 0.0198
2025-03-31 1,339.06 Cr 1,268.80 Cr 70.26 Cr 0.0525 40.42 Cr 25.69 Cr 5.91 56.21 Cr 0.0192
2024-12-31 1,359.00 Cr 1,225.59 Cr 133.40 Cr 0.0982 41.91 Cr 25.44 Cr 5.85 57.51 Cr 0.0187

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 75.70 Cr 273.29 Cr 349.00 Cr 998.63 Cr 700.13 Cr 2,127.30 Cr 161.02 Cr 2,851.34 Cr 1,054.69 Cr
2025-06-30 0.00 Cr 0.00 Cr 317.98 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,770.36 Cr
2025-03-31 260.42 Cr 57.56 Cr 317.98 Cr 830.44 Cr 659.78 Cr 2,075.71 Cr 132.06 Cr 2,702.52 Cr 932.16 Cr
2024-12-31 0.00 Cr 0.00 Cr 502.93 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,722.59 Cr
2024-09-30 80.65 Cr 3.19 Cr 453.83 Cr 880.71 Cr 598.70 Cr 2,034.92 Cr 134.31 Cr 2,652.90 Cr 930.31 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 27.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 25.69 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 25.44 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 23.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 20.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Distribution

Company Name Symbol Price Market Cap Volume
Entero Healthcare Solutions Limited ENTERO ₹1,033.50 ₹44,968,553,390.00 ₹90,891.00

Key Executives

Chief Growth Officer
Abhitesh Kumar

Gender: male

Year Born:

Group Chief Financial Officer
Balakrishnan Natesan Kaushik

Gender: male

Year Born:

Co-Founder, CEO, MD & Director
Prabhat Agrawal

Gender: male

Year Born: 1977

Co-Founder, Chief Operating Officer & Whole-time Director
Prem Sethi

Gender: male

Year Born: 1977

President of Institutional Business
Sambit Mohanty

Gender: male

Year Born:

Vice President of Legal and General Counsel, Company Secretary & Compliance Officer
Sanu Vishal Kapoor

Gender: female

Year Born: 1971

FAQs about Entero Healthcare Solutions Limited

Who is the CEO of the company?

The CEO is Prabhat Agrawal.

What is the current market price of the stock?

The current price is ₹1,032.00.

What is the 52-week price range?

The range is ₹944-1510.8.

What is the market capitalization of the company?

The market capitalization is ₹4,490.33 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 39.83.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Entero Healthcare Solutions Limited (ISIN: INE010601016) is a leading Medical - Distribution in India. With a market capitalization of ₹4,490.33 crores and an average daily volume of 146,057 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.